Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Affinity and avidity in antibody-based tumor targetingStephen I Rudnick, Gregory P Adams
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2008
Effects of local mRNA structure on posttranscriptional gene silencingStephen I Rudnick, Jyothishmathi Swaminathan, Marina Sumaroka, et al.
Molecular Pharmacology|October 12, 2004
Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymesDavid R Bauman, Stephen I Rudnick, Lawrence M Szewczuk, et al.
Blood|May 21, 2010
c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell developmentYuji Nakata, Anne C Brignier, Shenghao Jin, et al.
Molecular and Cellular Biology|January 24, 2007
c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expressionYuji Nakata, Susan Shetzline, Chizuko Sakashita, et al.
Cancer Research|March 17, 2011
Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumorsStephen I Rudnick, Jianlong Lou, Calvin C Shaller, et al.
Blood Cancer Journal|June 3, 2020
Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironmentPriyanka Nair-Gupta, Stephen I Rudnick, Leopoldo Luistro, et al.
Molecular Cancer Therapeutics|November 18, 2011
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicityYu Cao, James D Marks, Qian Huang, et al.
Pageof 1